Adropin is a novel 76-amino acid-peptide that is expressed in different tissues and cells
including the liver, pancreas, heart and vascular tissues, kidney, milk, serum, plasma and …

Adropin is a unique hormone encoded by the energy homeostasis-associated (Enho) gene.
Adropin is produced in the liver and brain, and also in peripheral tissues such as in the heart …

The peptidergic system is the most abundant network of ligand-receptor-mediated signaling
in humans. However, the physiological roles remain elusive for numerous peptides and …

Adropin, a peptide hormone expressed in liver and brain, is known to improve insulin
resistance and endothelial dysfunction. Serum levels of adropin are negatively associated …

Adropin is a peptide hormone, which plays a role in energy homeostasis and controls
glucose and fatty acid metabolism. Its levels correlate with changes in carbohydrate‐lipid …

Dysregulation of G protein-coupled receptors (GPCRs) is known to be involved in the
pathogenesis of a variety of diseases, including cancer initiation and progression. Within this …

Mitochondria supply~ 90% of the ATP required for contractile function in cardiac cells. While
adult cardiomyocytes preferentially utilize fatty acids as a fuel source for oxidative …

Fibrotic diseases impose a major socioeconomic challenge on modern societies and have
limited treatment options. Adropin, a peptide hormone encoded by the energy homeostasis …

Adropin is a nutritionally regulated peptide hormone, secreted primarily by the liver, which
modulates metabolic homeostasis in a number of tissues. Growing evidence suggests that …

Adropin is a highly-conserved peptide that has been shown to preserve endothelial barrier
function. Blood-brain barrier (BBB) disruption is a key pathological event in cerebral …